[Individualized DNA analysis in insurance medicine clarifications].
DNA investigations for the clarification of problems in insurance medicine can be subdivided into 3 groups (1) Traffic accidents (2) identification (3) questionable fraud cases. The development in individualisation by DNA analysis has progressed from the initial restriction fragment length polymorphisms (RFLPs) to the PCR-based polymorphisms. PCR systems are characterised by a very high sensitivity of detection and a high degree of success with highly degraded biological material. The current possibilities for DNA analysis are described and exemplified with special reference to PCR-based polymorphisms.